These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30026437)

  • 1. [Measuring Financial Toxicity in Japanese Cancer Patients].
    Honda K
    Gan To Kagaku Ryoho; 2018 May; 45(5):785-788. PubMed ID: 30026437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study.
    Honda K; Gyawali B; Ando M; Sugiyama K; Mitani S; Masuishi T; Narita Y; Taniguchi H; Kadowaki S; Ura T; Muro K
    Ecancermedicalscience; 2018; 12():847. PubMed ID: 30079109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer.
    Honda K; Gyawali B; Ando M; Kumanishi R; Kato K; Sugiyama K; Mitani S; Masuishi T; Narita Y; Bando H; Taniguchi H; Kadowaki S; Ura T; Muro K
    J Glob Oncol; 2019 May; 5():1-8. PubMed ID: 31070981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST).
    de Souza JA; Yap BJ; Wroblewski K; Blinder V; Araújo FS; Hlubocky FJ; Nicholas LH; O'Connor JM; Brockstein B; Ratain MJ; Daugherty CK; Cella D
    Cancer; 2017 Feb; 123(3):476-484. PubMed ID: 27716900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial toxicity in patients with cancer attending a public Australian tertiary hospital: A pilot study.
    McLean L; Hong W; McLachlan SA
    Asia Pac J Clin Oncol; 2021 Jun; 17(3):245-252. PubMed ID: 32894819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of financial toxicity and its associations with health-related quality of life and treatment non-adherence in Turkish cancer patients.
    Ürek D; Uğurluoğlu Ö
    Support Care Cancer; 2022 Jan; 30(1):865-874. PubMed ID: 34392415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol.
    Riva S; Bryce J; De Lorenzo F; Del Campo L; Di Maio M; Efficace F; Frontini L; Giannarelli D; Gitto L; Iannelli E; Jommi C; Montesarchio V; Traclò F; Vaccaro CM; Gallo C; Perrone F
    BMJ Open; 2019 Sep; 9(9):e031485. PubMed ID: 31501130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial toxicity of patients with lung cancer in China: Results from a National Survey Study.
    Liu M; Huang D; Liu Y
    Cancer Med; 2023 Feb; 12(4):4751-4760. PubMed ID: 36128854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported financial toxicity and adverse medical consequences in head and neck cancer.
    Beeler WH; Bellile EL; Casper KA; Jaworski E; Burger NJ; Malloy KM; Spector ME; Shuman AG; Rosko A; Stucken CL; Chinn SB; Dragovic AF; Chapman CH; Owen D; Jolly S; Bradford CR; Prince MEP; Worden FP; Jagsi R; Mierzwa ML; Swiecicki PL
    Oral Oncol; 2020 Feb; 101():104521. PubMed ID: 31877502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Universal Health Coverage and Cancer Drugs - A Cost-Effectiveness Perspective].
    Fukuda A; Igarashi A
    Gan To Kagaku Ryoho; 2016 Nov; 43(11):1311-1315. PubMed ID: 27899770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives.
    Saeki S; Iwatani T; Kitano A; Sakurai N; Tanabe Y; Yamauchi C; Igarashi A; Kajimoto Y; Kuba S; Hara F; Sagara Y; Ohno S;
    Breast Cancer; 2023 Sep; 30(5):820-830. PubMed ID: 37310584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financial Toxicity in Women With Breast Cancer Receiving Radiation Therapy: Final Results of a Prospective Observational Study.
    Yusuf M; Pan J; Rai SN; Eldredge-Hindy H
    Pract Radiat Oncol; 2022; 12(2):e79-e89. PubMed ID: 34896597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying a cut-off score for the COST measure to indicate high financial toxicity and low quality of life among cancer patients.
    Ng MSN; Choi KC; Chan DNS; Wong CL; Xing W; Ho PS; Au C; Chan M; Tong M; Ling WM; Chan M; Mak SSS; Chan RJ; So WKW
    Support Care Cancer; 2021 Oct; 29(10):6109-6117. PubMed ID: 33797583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of a Japanese version of the FLIE].
    Satou A; Yamazaki T; Nukariya N; Nakamachi M; Shimada K; Matsukawa M; Kurihara M
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):281-91. PubMed ID: 11865635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the financial toxicity in Tunisian cancer patients using the Comprehensive Score for Financial Toxicity (COST).
    Mejri N; Berrazega Y; Boujnah R; Rachdi H; El Benna H; Labidi S; Boussen H
    Support Care Cancer; 2021 Jul; 29(7):4105-4111. PubMed ID: 33404807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Financial Toxicity in Japanese Patients with Metastatic Renal Cell Carcinoma: A Cross-Sectional Study.
    Kimura G; Fujii Y; Honda K; Osawa T; Uchitomi Y; Kondo M; Otani A; Wako T; Kawai D; Mitsuda Y; Sakashita N; Shinohara N
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with increased financial toxicity after the completion of radiation treatment for gynecologic cancer.
    Esselen KM; Baig RA; Gompers A; Stack-Dunnbier H; Hacker MR; Jang JW
    Support Care Cancer; 2023 Jun; 31(7):388. PubMed ID: 37300721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of quality of life questionnaire in Japan: quality of life assessment of cancer patients receiving chemotherapy.
    Kurihara M; Shimizu H; Tsuboi K; Kobayashi K; Murakami M; Eguchi K; Shimozuma K
    Psychooncology; 1999; 8(4):355-63. PubMed ID: 10474853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of epidermal growth factor receptor inhibitor-induced dermatologic toxicities on quality of life.
    Joshi SS; Ortiz S; Witherspoon JN; Rademaker A; West DP; Anderson R; Rosenbaum SE; Lacouture ME
    Cancer; 2010 Aug; 116(16):3916-23. PubMed ID: 20564072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.